Authors: | Vaglio, A.; Diamond, E. L. |
Article Title: | Erdheim-Chester disease: The “targeted” revolution |
Abstract: | In this issue of Blood, Cohen Aubart et al present a large series of patients with Erdheim-Chester disease (ECD) treated with BRAF and MEK inhibitors and describe the disease trajectory in a subset of these patients after treatment withdrawal.1 © 2017 by The American Society of Hematology. |
Journal Title: | Blood |
Volume: | 130 |
Issue: | 11 |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2017-09-14 |
Start Page: | 1282 |
End Page: | 1284 |
Language: | English |
DOI: | 10.1182/blood-2017-07-795054 |
PROVIDER: | scopus |
PUBMED: | 28912295 |
DOI/URL: | |
Notes: | Note -- Export Date: 2 October 2017 -- Source: Scopus |